Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver Diamine Fluoride vs Chlorhexidine for anticandidal efficacy in severe early childhood caries
IRCT20201104049255N1Phase 4Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of silver diamine fluoride and chlorhexidine in early childhood caries (ECC) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Primary anticandidal efficacy. Started Jun 2021; status: completed.
02
Drugs
silver diamine fluoridechlorhexidine
03
Conditions
early childhood caries (ECC)
Beyond the preview
Go deeper on IRCT20201104049255N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201104049255N1.